Table 2 Creatinine, eGFR, proteinuria and ACE-I stratified by renal function at outset. Data are medians (range). Proteinuria*: b) vs c) p = 0.06, c) vs d) p = 0.031; -Δ eGFR †: b) vs c) p= 0.14, c) vs d) p = 0.012; Total -ΔGFR is the rate of change of function in ml/min/yr from start to last follow up; Rx ACEI is the percentage of patients receiving ACEI treatment
From: Renal outcome in adults with renal insufficiency and irregular asymmetric kidneys
Renal Function groups | N= | Creatinine | eGFR | Proteinuria | -Δ eGFR Total | -Δ eGFR post-ACEI | Rx ACEI |
|---|---|---|---|---|---|---|---|
μmol/l | ml/min/1.73 m2 | mg/mmol | ml/min/yr | ml/min/yr | |||
a) 15–30 ml/min | 16 | 295 (220–450) | 24 | 209 (57–680) | 2.94 (0.55–5.7) | 2.63 (1.51–4.3) | 38% |
b) 31–40 ml/min | 14 | 198 (160–233) | 36 | 200 (71–275)* | 3.05 (0.95–7.4) | 1.7 (0.9–3.45) | 50% |
c) 41–50 ml/min | 30 | 160 (130–185) | 46 | 100 (10–276)* | 1.71 (0.44–8.21)† | 1.68 (0.66–7.85) | 77% |
d) 51–60 ml/min | 18 | 130 (115–153) | 55 | 38* (10–250) | 1.34 (0.24–3.41)† | 1.76 (0.24–3.73) | 72% |